Clinical Trials Directory

Trials / Unknown

UnknownNCT06025903

Assessing the Role of Mitochondrial Dysfunction in Primary Progressive Multiple Sclerosis

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
IRCCS San Raffaele · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this project is to study genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis. Specific aims are: 1) identify mitochondrial-related pathways, inherited and somatic mitochondrial DNA mutations associated to primary progressive multiple sclerosis, 2) functionally assess the identified genetic alterations.

Detailed description

Multiple Sclerosis is a major cause of neurological disability, with a high socio-economic impact that increases as disability progresses. Effective treatment of primary progressive multiple sclerosis is still an unmet need and the underlying neurodegenerative processes have to be fully investigated. The purpose of this project is to study genetic determinants of mitochondrial impairment in primary progressive multiple sclerosis. Altered mitochondrial pathways will be investigate, as well as inherited and tissue-specific somatic mitochondrial variations associated with primary progressive multiple sclerosis.

Conditions

Timeline

Start date
2021-09-20
Primary completion
2024-09-30
Completion
2025-05-30
First posted
2023-09-06
Last updated
2024-03-22

Locations

2 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT06025903. Inclusion in this directory is not an endorsement.